Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
企業コードSNOA
会社名Sonoma Pharmaceuticals Inc
上場日Jan 26, 2007
最高経営責任者「CEO」Ms. Amy Trombly
従業員数168
証券種類Ordinary Share
決算期末Jan 26
本社所在地5445 Conestoga Court, Suite 150
都市BOULDER
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号80301
電話番号18007599305
ウェブサイトhttps://sonomapharma.com/
企業コードSNOA
上場日Jan 26, 2007
最高経営責任者「CEO」Ms. Amy Trombly
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし